ETF Managers Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-498,627
| Closed | -$46.3M | – | 760 |
|
|
2021
Q4 | $46.3M | Sell |
498,627
-183,489
| -27% | -$12.1M | 0.92% | 34 |
|
|
2021
Q3 | $40.9M | Sell |
682,116
-85,902
| -11% | -$5.07M | 0.77% | 47 |
|
|
2021
Q2 | $53.7M | Buy |
768,018
+41,571
| +6% | +$2.71M | 0.88% | 31 |
|
|
2021
Q1 | $50.4M | Buy |
726,447
+486,414
| +203% | +$37.4M | 0.9% | 36 |
|
|
2020
Q4 | $18.4M | Sell |
240,033
-17,796
| -7% | -$1.33M | 0.4% | 92 |
|
|
2020
Q3 | $19.3M | Sell |
257,829
-52,314
| -17% | -$3.49M | 0.61% | 55 |
|
|
2020
Q2 | $19.5M | Buy |
310,143
+7,830
| +3% | +$431K | 0.69% | 47 |
|
|
2020
Q1 | $12.7M | Sell |
302,313
-17,587
| -5% | -$806K | 0.59% | 58 |
|
|
2019
Q4 | $14.5M | Buy |
319,900
+58,729
| +22% | +$2.78M | 0.51% | 75 |
|
|
2019
Q3 | $12M | Sell |
261,171
-143,887
| -36% | -$8.09M | 0.43% | 80 |
|
|
2019
Q2 | $23.7M | Buy |
+405,058
| New | +$20.9M | 0.76% | 46 |
|
|
2019
Q1 | – | Sell |
-316,684
| Closed | -$12.3M | – | 588 |
|
|
2018
Q4 | $12.3M | Buy |
316,684
+114,123
| +56% | +$4.48M | 0.58% | 42 |
|
|
2018
Q3 | $8.78M | Buy |
202,561
+69,137
| +52% | +$2.8M | 0.33% | 71 |
|
|
2018
Q2 | $44 | Buy |
133,424
+18,534
| +16% | +$797K | ﹤0.01% | 470 |
|
|
2018
Q1 | $4.06M | Buy |
114,890
+60,878
| +113% | +$2.37M | 0.25% | 78 |
|
|
2017
Q4 | $1.96M | Buy |
+54,012
| New | +$1.54M | 0.14% | 84 |
|
ETF Managers Group's ARNA Position: Q1 2022 in Review
ETF Managers Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 498,627 shares — an estimated $46.3M sold.
ETF Managers Group first reported a position in ARNA in Q4 2017 and held it in 16 quarters. The position peaked at $53.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- ETF Managers Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- ETF Managers Group sold 498,627 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $46.3M.
- ETF Managers Group first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 16 quarters.
- ETF Managers Group's Arena Pharmaceuticals Inc position peaked at $53.7M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on ETF Managers Group's 13F filing for Q1 2022, filed 13 May 2022.